$Virax Biolabs (VRAX.US)$
Virax Biolabs Announces 2025 Strategic Priorities, Highlighting Clinical Validation For Viraximmune And Global Expansion of ImmuneSelect
Virax Biolabs Announces 2025 Strategic Priorities, Highlighting Clinical Validation For Viraximmune And Global Expansion of ImmuneSelect
1
$Virax Biolabs (VRAX.US)$ 。
Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland
LONDON, December 10, 2024 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that it has entered into a non-exclusive distribution agreement with French company to exp...
Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland
LONDON, December 10, 2024 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that it has entered into a non-exclusive distribution agreement with French company to exp...